Clinical Trials List
2013-10-14 - 2021-03-05
Phase III
Terminated4
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- 邱仁輝 Division of General Surgery
- 金光亮 Division of General Surgery
- 王國鐘 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- 賴鴻文 Division of General Surgery
- 曾信順 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- YEN-SHEN LU Division of General Surgery
- 林柏翰 Division of General Surgery
- 林璟宏 Division of General Surgery
- 張端瑩 Division of General Surgery
- 郭文宏 Division of General Surgery
- Wei-Wu Chen Division of General Surgery
- MING-YANG WANG Division of General Surgery
- 羅喬 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
431 participants
